All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
Bookmark this article
During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke with Lori Muffly, Stanford Medicine, Stanford, US. We asked about the geographical barriers to accessing specialty cancer care among adolescents and young adults with ALL.
What are the geographical barriers to accessing specialty cancer care among young adults with ALL?
Muffly discusses the geographical barriers to receiving specialty cancer care among young adolescent patients with ALL. Research was conducted to quantify the distance between patient residences and treatment centers, such as National Cancer Institute designated cancer centers or Children’s Oncology Group sites. She then discusses the results, highlighting long travel times as a significant geographical barrier to accessing care across the U.S. and concluding that more networks and centers are needed.
Does adding inotuzumab ozogamicin to frontline therapy improve survival outcomes for adults with B-ALL?
During the 64th American Society of Hematology (ASH) Annual Meeting and Exposition, the ALL Hub spoke with Nicholas Short, MD Anderson Cancer...
Blinatumomab in newly diagnosed adult patients with ALL in MRD negative remission: Results from ECON-ACRIN E1910
The addition of blinatumomab to consolidation chemotherapy resulted in improved overall survival in patients with newly diagnosed B-ALL...
Subscribe to get the best content related to ALL delivered to your inbox